Title:Small Molecules as SIRT Modulators
VOLUME: 18 ISSUE: 13
Author(s):Xinfa Bai, Lei Yao*, Xuan Ma and Xiangming Xu
Affiliation:School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, Department of Gastroenterology, Linyi People's Hospital, Linyi, Shandong, 276003
Keywords:Class III histone deacetylases, modulators, Sirtuin, small molecules, SuRT, Virus infection.
Abstract:Sirtuins are a family of NAD+-dependent deacetylases (class III histone deacetylases). Seven
mammalian sirtuins, SIRT1-7, are identified, as the functions and locations differ greatly. SIRT1 and
SIRT2 locate in nucleus and cytoplasm, while SIRT3-5 in mitochondria. Sirtuins are not only involved in
many important biological processes such as apoptosis, cellular senescence, endocrine signaling, glucose
homeostasis, aging, and longevity, it can also control circadian clocks and mitochondrial biogenesis.
Small molecules that can modulate the sirtuins activity have been shown to have potentials for treating
many human diseases such as type II diabetes, cancer, rheumatoid arthritis, cardiovascular and other
age-relating diseases. Some polyphenolic natural products such as Resveratrol, Fisetin, and Quercetin
have demonstrated health benefits due to their SIRT1 activation effects. Some structurally diverse synthetic
compounds, such as SRT1720, SRT1460, Selisistat (EX 527), and AGK2 were used as small
molecular SIRT modulators (IC50 = 0.04-100 μM) to treat ischemic stroke, myocardial infarction, neurodegenerative
diseases, cancer, aging, and obesity.
In order to get better understanding of how the small molecules interact with the sirtuin, the small
molecules that having SIRT inhibitory or activation effect, found by HTS or other modern medicinal
chemistry techniques, are reviewed in this article.
